562
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Tuberculosis, Airway Obstruction and Mortality in a Finnish Population

, , , , &
Pages 143-149 | Received 02 May 2016, Accepted 14 Oct 2016, Published online: 23 Nov 2016

References

  • World Health Organization (WHO). Global Tuberculosis report 2015. Feb. 29, 2016. Available from: http://www.who.int/tb/publications/global_report/en/.
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Feb. 29, 2016. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html, http://www.goldcopd.org/guidelines-pocket-guide-to-copd-diagnosis.html (accessed December 2015).
  • The National Tuberculosis Program of Finland from the year 2013 (summary in English, the whole text available only in Finnish). Feb. 29, 2016. Available from: http://urn.fi/URN:ISBN:978-952-00-3414-6.
  • Leung CC, Yew WW, Chan CK, Tam CM, Lam CW, Chang KC, et al. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2003; 7(10):980–986.
  • Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis 2011; 15(7):871–885.
  • Christensen AS, Roed C, Andersen PH, Andersen AB, Obel N. Long-term mortality in patients with pulmonary and extrapulmonary tuberculosis: a Danish nationwide cohort study. Clin Epidemiol 2014; 6:405–421.
  • Chakrabarti B, Calverley PM, Davies PD. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007; 2(3):263–272.
  • Inghammar M, Ekbom A, Engström G, Ljungberg B, Romanus V, Löfdahl CG, et al. COPD and the risk of tuberculosis—a population-based cohort study. PLoS One 2010; 13; 5(4):e10138.
  • Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167(4):335–342.
  • Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med 1989; 83(3):195–198.
  • Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest 2007; 131(6):1817–1824.
  • Rhee CK, Yoo KH, Lee JH, Park MJ, Kim WJ, Park YB, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis 2013; 17(1):67–75.
  • Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airways disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971; 103(5):625–640.
  • Lee SW, Kim YS, Kim D-S, Oh Y-M, Lee S-D. The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci 2011; 26(2):268–273.
  • Lam KB, Jiang CQ, Jordan RE, Miller MR, Zhang WS, Cheng KK, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest 2010; 137(3):593–600.
  • Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J 2015; 46(4):1104–1112. doi: 10.1183/13993003.02325-2014. [ Published Online First June 25, 2015].
  • Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration 2013; 86(1):76–85. doi: 10.1159/000350917. [ Published Online First May 3, 2013.
  • Ross J, Ehrlich RI, Hnizdo E, White N, Churchyard GJ. Excess lung function decline in gold miners following pulmonary tuberculosis. Thorax 2010; 65(11):1010–1015.
  • Tala-Heikkilä M. Tuberkuloosi Suomessa. Aikakauskirja Duodecim 2003; 119(17):1621–1628. ( in Finnish).
  • Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J, Joukamaa M, et al. Health, functional limitations and need for care in Finland. Basic results from the Mini-Finland Health Survey (in Finnish with English Summary). Helsinki and Turku, Publications of the Social Insurance Institution 1989.
  • Aromaa A, Heliövaara M, Knekt P, Reunanen A, Impivaara O, Maatela J. Cardiovascular and Respiratory Survey Methods. Part 2 (in Finnish with English summary). Helsinki and Turku: Publications of the Social Insurance Institution, 1985.
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948–968.
  • Mattila T, Vasankari T, Kanervisto M, Laitinen T, Impivaara O, Rissanen H, et al. Association between all-cause and cause-specific mortality and the GOLD stages 1–4: a 30-year follow-up among Finnish adults. Respir Med 2015; 109(8):1012–1018.
  • Brändli O, Schindler C, Künzli N, Keller R, Perruchoud AP. Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. Thorax 1996; 51(3):277–283.
  • Kertsjens HA, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997; 52(9):820–827.
  • Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley; 1981.
  • Statistics Finland. 2008. The key between the short list in the time series of the causes of death since 1969 and the earlier classifications. Available from: http://www.stat.fi/index_en.html, http://www.stat.fi/til/ksyyt/2005/ksyyt_2005_2006-10-31_luo_002.html. (accessed July 30, 2016)
  • Jordan TS, Spencer EM, Davies P. Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 2010; 15(4):623–628.
  • Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7(12):845–855. [ Published Online First October 26, 2009].
  • Liestøl K, Tretli S, Tverdal A, Maehlen J. Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910–49. Int J Epidemiol 2009; 38(2):427–434.
  • Zellweger JP, Heinzer R, Touray M, Vidondo B, Altpeter E. Intra-observer and overall agreement in the radiological assessment of tuberculosis. Int J Tuberc Lung Dis 2006; 10(10):1123–1126.
  • Abubakar I, Story A, Lipman M, Bothamley G, van Hest R, Andrews N, et al. Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population. Eur Respir J 2010; 35(3):689–692.
  • Cohen R, Muzaffar S, Capellan J, Azar H, Chinikamwala M. The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996; 109(2):420–423.
  • Graham S, Das GK, Hidvegi RJ, Hanson R, Kosiuk J, Al ZK, et al. Chest radiograph abnormalities associated with tuberculosis: reproducibility and yield of active cases. Int J Tuberc Lung Dis 2002; 6(2):137–142.
  • Balabanova Y, Coker R, Fedorin I, Zakharova S, Plavinskij S, Krukov N, et al. Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: observational study. BMJ 2005; 331(7513):379–382.
  • Joshi R, Patil S, Kalantri S, Schwartzman K,Menzies D,Pai M. Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response. PLoS ONE 2007; 2(8):e805. doi: 10.1371/journal.pone.0000805.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.